Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis ; volume:18 ; number:1 ; day:22 ; month:6 ; year:2023 ; pages:1-12 ; date:12.2023
Journal of orthopaedic surgery and research ; 18, Heft 1 (22.6.2023), 1-12, 12.2023
- Creator
-
Yuan, Chuanjian
Liang, Yanchen
Zhu, Kai
Xie, Wenpeng
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13018-023-03920-4
- URN
-
urn:nbn:de:101:1-2023092508272059604775
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yuan, Chuanjian
- Liang, Yanchen
- Zhu, Kai
- Xie, Wenpeng
- SpringerLink (Online service)
Other Objects (12)
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?
A reappraisal of generic bisphosphonates in osteoporosis
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Medication-related osteonecrosis of the jaw : bisphosphonates, denosumab, and new agents
Glucocorticoid induced osteoporosis : 12 tables
Glucocorticoid-induced osteoporosis: an update
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?
A reappraisal of generic bisphosphonates in osteoporosis
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Medication-related osteonecrosis of the jaw : bisphosphonates, denosumab, and new agents
Glucocorticoid induced osteoporosis : 12 tables
Glucocorticoid-induced osteoporosis: an update
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?
A reappraisal of generic bisphosphonates in osteoporosis
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Medication-related osteonecrosis of the jaw : bisphosphonates, denosumab, and new agents
Glucocorticoid induced osteoporosis : 12 tables